Pascal Maire

Author PubWeight™ 35.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Six1 is required for the early organogenesis of mammalian kidney. Development 2003 2.47
2 The Hill equation: a review of its capabilities in pharmacological modelling. Fundam Clin Pharmacol 2008 2.44
3 Muscle contraction is necessary to maintain joint progenitor cell fate. Dev Cell 2009 2.09
4 Altered myogenesis in Six1-deficient mice. Development 2003 1.92
5 Six1 and Six4 homeoproteins are required for Pax3 and Mrf expression during myogenesis in the mouse embryo. Development 2005 1.70
6 Thymus, kidney and craniofacial abnormalities in Six 1 deficient mice. Mech Dev 2003 1.52
7 Eya1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid. Development 2002 1.49
8 Six1 and Eya1 expression can reprogram adult muscle from the slow-twitch phenotype into the fast-twitch phenotype. Mol Cell Biol 2004 1.39
9 Quantitative proteomic identification of six4 as the trex-binding factor in the muscle creatine kinase enhancer. Mol Cell Biol 2004 1.17
10 Six proteins regulate the activation of Myf5 expression in embryonic mouse limbs. Proc Natl Acad Sci U S A 2007 1.14
11 Eya1 and Eya2 proteins are required for hypaxial somitic myogenesis in the mouse embryo. Dev Biol 2006 1.14
12 Patterning of the third pharyngeal pouch into thymus/parathyroid by Six and Eya1. Dev Biol 2006 1.13
13 Six1 and Six4 gene expression is necessary to activate the fast-type muscle gene program in the mouse primary myotome. Dev Biol 2009 1.06
14 Six and Eya expression during human somitogenesis and MyoD gene family activation. J Muscle Res Cell Motil 2002 1.04
15 Six1 regulates stem cell repair potential and self-renewal during skeletal muscle regeneration. J Cell Biol 2012 1.03
16 Six1 is not involved in limb tendon development, but is expressed in limb connective tissue under Shh regulation. Mech Dev 2004 0.99
17 Six homeoproteins directly activate Myod expression in the gene regulatory networks that control early myogenesis. PLoS Genet 2013 0.95
18 Genesis of muscle fiber-type diversity during mouse embryogenesis relies on Six1 and Six4 gene expression. Dev Biol 2011 0.92
19 Aminoglycoside nephrotoxicity: modeling, simulation, and control. Antimicrob Agents Chemother 2003 0.90
20 Aminoglycoside dosages and nephrotoxicity: quantitative relationships. Clin Pharmacokinet 2003 0.88
21 Comparison of four renal function estimation equations for pharmacokinetic modeling of gentamicin in geriatric patients. Antimicrob Agents Chemother 2012 0.88
22 Mathematical modeling of pulmonary tuberculosis therapy: Insights from a prototype model with rifampin. J Theor Biol 2011 0.84
23 Fiber-type specific and position-dependent expression of a transgene in limb muscles. Differentiation 2002 0.82
24 [Amikacin pharmacokinetics in adults: a variability that question the dose calculation based on weight]. Therapie 2009 0.81
25 Evaluation of various gentamicin dosage regimens in geriatric patients: a simulation study. Fundam Clin Pharmacol 2009 0.80
26 Evaluation of fluoroquinolone reduced dosage regimens in elderly patients by using pharmacokinetic modelling and Monte Carlo simulations. J Antimicrob Chemother 2012 0.80
27 Comment: modification of diet in renal disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination. Ann Pharmacother 2009 0.77
28 Visual estimation of patients' body weight in hospital: the more observers, the better? Pharm World Sci 2009 0.77
29 The value of population pharmacokinetics and simulation for postmarketing safety evaluation of dosing guidelines for drugs with a narrow therapeutic index: buflomedil as a case study. Fundam Clin Pharmacol 2011 0.76
30 Sodium intake and blood pressure in healthy individuals. J Hypertens 2003 0.76
31 [Cost-effectiveness analysis of active TDM in elderly patients treated with aminoglycosides]. Therapie 2011 0.75
32 The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy. Curr Pharm Des 2014 0.75
33 [New insights into adult muscle fiber-type diversity: involvement of Six homeoproteins]. Bull Acad Natl Med 2015 0.75
34 [Redeployment of the Six genes in evolution]. Med Sci (Paris) 2004 0.75
35 N-Hydroxy and N-acyloxy peptides: synthesis and chemical modifications. Org Biomol Chem 2006 0.75